This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Another unifying health care issue is prescriptiondrugprices, which KFF has tracked for several years. Most voters across party have told previous KFF polls they believe in more government regulation or intervention on drug costs.
” The first chart illustrates the top sources of stress gauged in each of the past four years of this survey since 2016. Healthcare Consumer Survey from TransAmerica ‘s Center for Health Studies underscores that Americans are “settling in” during a phase of “healthcare uncertainty.”
Congress this week on the topic of prescriptiondrug costs. One of those medicines, insulin, cost a patient $5,705 for a year’s supply in 2016, double what it cost in 2012, according to the Health Care Cost Institute. In typical markets, as products mature and get mass adoption, prices fall.
Even seemingly popular plan ideas like prescriptiondrugpricing and coverage for pre-existing conditions can’t get traction in Congress or through the White House’s executive pen. One on which I focus in my book is connectivity. In May 2017, AMIA called for the same , and the issue is getting the traction it merits.
We organize all of the trending information in your field so you don't have to. Join 26,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content